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b-Arrestin 2 Inhibits Proinflammatory Chemokine
Production and Attenuates Contact Allergic
Inflammation in the Skin
Evelyn Gaffal1, Mira Jakobs1, Nicole Glodde1, Ralf Schro¨der2, Evi Kostenis2 and Thomas Tu¨ting1
b-Arrestins participate in G-protein receptor signaling and act as adapter proteins that direct the recruitment,
activation, and scaffolding of various cytoplasmic signaling complexes. b-Arrestin 2–deficient (Arrb2 / ) mice
show decreased T-cell recruitment into allergic lung tissue but increased neutrophil infiltration into wounded
skin. Given these opposing effects in different immune cell subsets, we investigated the role of b-arrestin 2 in the
regulation of contact hypersensitivity responses. We observed significantly increased allergic ear swelling to the
obligate contact sensitizers DNFB and FITC in Arrb2 / compared with wild-type mice. Immunohistological
analyses revealed strikingly increased neutrophil infiltration with abundant subcorneal pustules in inflamed ear
tissue of DNFB-allergic Arrb2 / mice. Experiments involving adoptive transfers of sensitized lymphocytes and
bone marrow chimeric mice indicated that b-arrestin 2 exerts its anti-inflammatory effects predominantly through
radioresistant, skin-resident cells in the challenge phase of contact hypersensitivity. As a potential mechanism, we
found that primary cultures of b-arrestin 2–deficient keratinocytes secreted higher levels of neutrophil-attracting
chemokines including CXCL1/KC in response to T cell–derived cytokines in vitro. These experimental results
support a model in which b-arrestin 2 inhibits the production of proinflammatory chemokines, which limits the
recruitment of myeloid immune cells and thereby attenuates allergic skin inflammation.
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INTRODUCTION
G protein–coupled receptors (GPCRs) transmit environmental
signals and thereby coordinate cellular responses to environ-
mental stimuli. b-Arrestin 1 and 2 are adapter proteins that
were primarily shown to terminate GPCR signaling through
receptor desensitization and internalization (Zhang et al.,
1997; Lefkowitz and Shenoy, 2005). More recently, it
became evident that they also act as scaffold proteins for
multiple signaling molecules. For example, they link GPCR
signaling to ERK1/2, Akt, and Src kinases (DeWire et al., 2007)
and interact with the transcription factors NF-kB (Gao et al.,
2004; Witherow et al., 2004) and STAT1 (Mo et al., 2008). On
the basis of these observations, b-arrestins have emerged as
key regulators of several cell functions (Lefkowitz, 1998)
including the control of GPCR-dependent chemotactic
signals in immune cells during inflammatory reactions. T and
B lymphocytes of b-arrestin 2–deficient animals (Arrb2 / )
showed impaired migration toward stimulation with stromal
cell–derived factor-1a (SDF-1a/CXCL12) in vitro (Fong et al.,
2002). In an experimental model for ovalbumin-induced
allergic asthma, Arrb2 / mice displayed reduced infiltra-
tion of inflamed lung tissue with T cells and eosinophils
(Walker et al., 2003). These findings pointed toward a positive
regulatory role for b-arrestin 2 in lymphocyte chemotaxis.
However, Arrb2 / mice also showed increased CXCL1-
mediated migration of neutrophils in a skin air pouch model
of inflammation. Accordingly, wound excision experiments
revealed elevated infiltration of neutrophils into injured
skin of Arrb2 / mice (Su et al., 2005). Thus, b-arrestin
2 negatively regulates neutrophil chemotaxis.
Given these opposing effects of b-arrestin 2 on different
immune cell subsets, we investigated its role in experimental
contact hypersensitivity (CHS), a neutrophil-rich inflammatory
response in the skin that is driven by allergen-specific
T lymphocytes. In this model for allergic contact dermatitis,
highly reactive small molecules such as DNFB act as obligate
contact sensitizers. They are called haptens because they elicit
an immune response only after covalent binding to larger self-
proteins. In the sensitization phase, hapten-self complexes are
taken up by skin dendritic cells. Proinflammatory mediators
promote dendritic cell activation and migration to the regional
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lymph nodes where they stimulate hapten-specific T cells
(Kaplan et al., 2012). Upon subsequent exposures of the skin
to the hapten, epidermal keratinocytes alert antigen-specific
effector T cells, which then secrete cytokines such as tumor
necrosis factor-a (TNF-a) or IFN-g and cytotoxic molecules
such as perforin or granzyme B. Damaged keratinocytes
exposed to T cell–derived cytokines respond with the produc-
tion of more proinflammatory cytokines and chemokines,
which further promote the recruitment of myeloid immune
cells, most notably neutrophils. This initially amplifies the
inflammatory response but eventually contributes to repair
and regeneration of the disrupted epidermal barrier function
(Albanesi, 2010; Christensen and Haase, 2012; Gaffal et al.,
2013).
In our work, we found that Arrb2 / mice developed
significantly increased CHS responses with strikingly increased
neutrophil infiltration and abundant subcorneal pustules when
compared with wild-type (WT) control animals. Experiments
involving adoptive transfers of sensitized lymphocytes, bone
marrow chimeric mice, and primary cell cultures revealed an
unexpected role for b-arrestin 2 in radioresistant cells. We
found that b-arrestin 2 inhibits the production of proinflam-
matory chemokines in cultured epidermal keratinocytes in
response to T cell–derived cytokines in vitro and in T cell–
driven allergic skin inflammation in vivo.
RESULTS
Mice genetically deficient for b-arrestin 2 show enhanced CHS
responses
In initial studies, we comparatively examined CHS responses
to DNFB in Arrb2 / and WT C57BL/6 mice, as shown in
Figure 1a. The increase in ear thickness after DNFB challenge
was significantly higher in sensitized Arrb2 / mice com-
pared with WT mice (Figure 1b). CHS responses to DNFB are
primarily mediated by CD8þ cytotoxic T cells and type 1
CD4þ T-helper cells. We therefore additionally studied CHS
responses to FITC, which are mediated primarily by type 2
CD4þ T-helper cells, as shown in Figure 1c. Again we found
significantly stronger CHS responses in sensitized Arrb2 /
when compared with WT mice (Figure 1d). In contrast, acute
ear swelling responses to the irritant 12-O-Tetradecanoylphor-
bol 13-acetate were similar in Arrb2 / and WT mice
(Figure 1e and f). These results demonstrated an anti-inflam-
matory role for b-arrestin 2 in the regulation of contact allergic
inflammation.
Enhanced CHS responses in mice lacking b-arrestin 2 are
associated with increased neutrophil-rich inflammation and
subcorneal pustules
Histopathologic investigations of inflamed ear tissues 48 hours
after the second challenge with DNFB revealed prominent
tissue edema and increased numbers of infiltrating immune
cells, in particular neutrophils, which often aggregated in
subcorneal pustules, in sensitized Arrb2 / mice when
compared with WT mice (Figure 2a). Immunohistochemical
analyses confirmed the infiltration with large numbers of
Gr1þ immune cells in Arrb2 / mice (Figure 2b). Flow
cytometric analyses revealed a predominance of Ly6Cþ /Gþ
and CD11bþ immune cells (Figure 2b and c). Consistent with
these morphologic and immunologic observations, we mea-
sured significantly increased mRNA expression levels of Il1b,
S100a8, and Cxcl2, which code for proinflammatory media-
tors known to be secreted in large amounts by neutrophils,
in inflamed ear tissue of Arrb2 / mice (Figure 2d). These
results pointed toward an anti-inflammatory role for b-arrestin
2 in the regulation of contact allergic skin inflammation.
b-Arrestin 2 exerts its anti-inflammatory effects predominantly in
the challenge phase of CHS responses
In the experimental model for ovalbumin-induced allergic
asthma, Arrb2 / mice showed decreased numbers of T cells
infiltrating inflamed lung tissue (Walker et al., 2003).
However, in DNFB-induced contact allergic dermatitis, we
did not find significant differences between the number of
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Figure 1. Increased contact allergic ear swelling in mice genetically deficient
for b-arrestin 2. (a) Experimental protocol for DNFB-induced contact
hypersensitivity (CHS) responses. C, challenge; M, measurement of ear
thickness; S, sensitization. (b) Mean ear swelling over time (±SEM, n¼ 5 mice
per group). (c) Experimental protocol for FITC-induced CHS responses. (d)
Mean ear swelling on day 15 (±SEM, n¼ 5 per group). (e) Experimental
protocol for 12-O-tetradecanoylphorbol-13-acetate (TPA)-induced acute
irritative dermatitis. (f) Mean ear swelling over time (±SEM, n¼ 5 per group).
All experiments were repeated at least two times with similar results. *Po0.05,
**Po0.01.
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CD3þ T cells infiltrating inflamed skin tissue in Arrb2 /
and WT mice (Figure 3a and b). Interestingly, the mRNA levels
of Ifng and Tnfa, two cytokines produced by hapten-specific
effector T cells and innate immune cells such as NK cells and
macrophages, was increased in Arrb2 / mice when com-
pared with WT animals (Figure 3c). To further investigate a
potential role for b-arrestin 2 in lymphocytes during the CHS
response to DNFB, we adoptively transferred bulk lympho-
cytes isolated from lymph nodes and spleens of sensitized
Arrb2 / or WT mice into naı¨ve recipient WT or Arrb2 /
mice and determined the magnitude of allergic ear swelling
upon subsequent allergen challenges (Figure 3d). We found
that Arrb2 / mice that received sensitized lymphocytes from
WT or Arrb2 / mice elicited stronger CHS responses than
WT mice that received sensitized lymphocytes from WT or
Arrb2 / mice (Figure 3e). These results suggested that
b-arrestin 2 has an important role during the challenge phase
of CHS also in cells other than lymphocytes.
Radioresistant cells contribute to the anti-inflammatory activity
of b-arrestin 2
On the basis of the previously published inhibitory role of
b-arrestin 2 for CXCR2-mediated neutrophil recruitment in
the air pouch model for skin inflammation (Su et al., 2005),
we hypothesized that b-arrestin 2 acts in myeloid immune
cells such as neutrophils and macrophages by limiting their
recruitment into the skin of sensitized mice upon a sub-
sequent challenge with the contact allergen. To investigate
this possibility, we generated bone marrow chimeric mice in
which b-arrestin 2 was either expressed on radiosensitive
immune cells or on radioresistant host cells. We irradiated two
groups each of WT and Arrb2 / mice and reconstituted
them with bone marrow derived from either WT or Arrb2 /
mice. After 6 weeks, we sensitized and challenged these bone
marrow chimeric mice with DNFB (Figure 4a). We observed
that Arrb2 / mice reconstituted with bone marrow from WT
mice or Arrb2 / mice exhibited significantly enhanced CHS
responses when compared with WT mice reconstituted with
bone marrow from WT mice or Arrb2 / mice (Figure 4b).
These results argued against a predominant role for b-arrestin
2 on radiosensitive immune cells including neutrophils and
macrophages. Instead, they suggested that the anti-inflamma-
tory activity of b-arrestin 2 largely resides in radioresistant cells
in the skin.
b-Arrestin 2 inhibits the secretion of proinflammatory
chemokines by keratinocytes
Epidermal keratinocytes are the predominant radioresistant
cell type in the skin. They rapidly respond to disturbances of
the epidermal barrier, including exposure to contact sensiti-
zers, and are key players in the regulation of CHS responses
(Albanesi, 2010). By secreting proinflammatory chemokines in
response to inflammatory cytokines such as TNF-a or IFN-g,
which are produced by infiltrating immune cells including
allergen-specific T cells, they promote the recruitment of
myeloid immune cells, which help orchestrate tissue
regeneration and restoration of epidermal integrity (Gaffal
et al., 2013). We therefore considered a role for b-arrestin
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Figure 2. Prominent neutrophil-rich inflammation and subcorneal pustules in
contact allergic skin of Arrb2 / mice. (a) Representative hematoxylin and
eosin (H&E)-stained sections of inflamed ear tissue harvested from Arrb2 /
and wild-type (WT) mice 48 hours after the second challenge with DNFB
(left: original magnification 50 , bar¼ 500mm; right: original magnification
400, bar¼100mm, inset bar¼ 10mm). (b) Corresponding immunostained
sections for the myeloid cell marker Gr1 (original magnification 200,
bar¼ 100mm, left) and mean numbers of Gr1þ cells per high-power field
(HPF) (±SEM, n¼5 per group, right). (c) Representative flow cytometric dot
plots for Ly6Gþ Ly6Cþ cells in the CD45þCD11bþ gate (left) and mean
percentage of cells (±SEM, n¼ 5 per group, right). (d) Mean mRNA expression
levels of Il1b, S100a8, and Cxcl2 relative to ubiquitin determined by
quantitative real-time reverse-transcriptase–PCR (2DCT ±SEM, n¼ 5 per
group). **Po0.01; ***Po0.001.
E Gaffal et al.
b-Arrestin 2 Attenuates CHS
www.jidonline.org 2133
2 in regulating these important keratinocyte functions. Primary
cultures of epidermal keratinocytes established from the skin
of newborn b-arrestin 2–deficient animals proliferated and
differentiated normally in vitro when compared with cultures
derived from newborn WT mice. Next, we determined the
secretion of the TNF-a-inducible chemokines CCL2 and
CXCL1, as well as the IFN-g-inducible chemokines CCL8
and CXCL10. We consistently found higher levels of CCL2
and CXCL1 in the supernatants of near-confluent primary
b-arrestin 2–deficient keratinocyte cultures under basal and
TNF-a-induced inflammatory conditions (Figure 5a). Follow-
ing stimulation with IFN-g, we also observed increased levels
of CCL8 but not of CXCL10 in b-arrestin 2–deficient kerati-
nocytes (Figure 5b). Consistent with our in vitro findings, we
detected significantly increased mRNA expression levels of
Ccl2, Cxcl1, and Ccl8 in contact allergic ear tissue of Arrb2 /
when compared with WT mice (Figure 5c). From these results,
we concluded that b-arrestin 2 in epidermal keratinocytes
inhibits the production of proinflammatory chemokines parti-
cularly in response to TNF-a and IFN-g, two cytokines
secreted by allergen-specific T cells.
DISCUSSION
In this study, we investigated the role of b-arrestin 2 for the
regulation of allergic inflammation in the experimental mouse
model of CHS. We found that mice genetically deficient for
the adapter protein b-arrestin 2 develop an increased and
persistent contact allergic ear swelling in response to the
obligate contact sensitizers DNFB and FITC when compared
with WT control animals. Histopathological analyses revealed
strikingly increased neutrophil infiltration and abundant sub-
corneal pustules in inflamed ear tissue of DNFB-challenged
Arrb2 / mice. These observations support a predominant
negative regulatory role of b-arrestin 2 for neutrophil
recruitment into inflamed skin, consistent with previously
reported experimental results in skin wound healing
experiments, where increased neutrophil infiltration was
observed in Arrb2 / when compared with WT mice
(Su et al., 2005).
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Figure 3. b-Arrestin 2 deficiency affects the challenge phase of contact hypersensitivity responses. (a) Representative CD3-stained sections of inflamed ear tissue
harvested from Arrb2 / and wild-type (WT) mice 48 hours after the second challenge with DNFB (original magnification  200, bar¼ 100mm). (b) Mean
numbers of CD3þ cells per high-power field (HPF) (±SEM, n¼ 5 per group). (c) Mean mRNA expression levels of Ifng and Tnfa relative to ubiquitin determined
by quantitative real-time reverse-transcriptase–PCR (2DCT±SEM, n¼5 per group). (d) Experimental protocol for adoptive lymphocyte (LC) transfer experiments.
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The previously described role for b-arrestin 2 in T lympho-
cytes during experimentally induced allergic inflammation in
lung tissue (Walker et al., 2003) appeared not to be of
prominent importance for contact allergic skin inflammation,
as evidenced by similar numbers of CD3þ T cells in inflamed
ear tissues of Arrb2 / and WT mice and by comparable
CHS responses following adoptive transfer of sensitized
lymphocytes from Arrb2 / or WT mice. The observed
differences in the two experimental systems may reflect
fundamental differences in tissue-specific control of inflam-
matory responses.
b-Arrestin 2 deficiency has been shown to result in
enhanced CXCL1-dependent neutrophil chemotaxis in the
skin air pouch model, indicating enhanced activation of
CXCR2 signaling in myeloid immune cells in vivo (Su et al.,
2005). As a potential underlying mechanism, it was reported
that b-arrestin 2 is required for the induction and strengthening
of integrin-mediated leukocyte adhesion during CXCR2-driven
extravasation (Molteni et al., 2009). However, our experiments
with bone marrow chimeric mice provided evidence that the
ability of b-arrestin 2 to attenuate the challenge phase of CHS
responses resides predominantly in radioresistant cells and not
in radiosensitive immune cells such as neutrophils or
macrophages. As a potential explanation for this finding, we
discovered that primary cultures of epidermal keratinocytes
established from b-arrestin 2–deficient mice produced signifi-
cantly increased amounts of the proinflammatory chemokines
CCL2, CXCL1, and CCL8 in response to TNF-a and IFN-g, two
cytokines secreted by allergen-specific T cells. The significantly
increased mRNA expression levels of Ccl2, Cxcl1, and Ccl8 in
contact allergic ear tissue of Arrb2 / mice further supported
the notion that the deregulated production of proinflammatory
chemokines in b-arrestin 2–deficient keratinocytes may con-
tribute to enhanced neutrophil recruitment and subsequently
increased CHS responses. Our experimental findings are
consistent with the important role of epidermal keratinocytes
in the regulation of skin inflammatory responses that has
emerged in recent years (Wittmann and Werfel, 2006;
Albanesi, 2010; Gaffal et al., 2013).
Our studies so far do not directly prove that the deregulated
production of proinflammatory chemokines by b-arrestin
2–deficient keratinocytes in vitro represents the key mechanism
how CHS responses are increased in Arrb2 / mice in vivo.
Evidence for a role of b-arrestins in keratinocytes has so far
only been reported in the two-stage mouse skin carcinogenesis
model (Chun et al., 2009, 2010). It is also conceivable
that b-arrestin 2 has an important role in mast cells, which
are relatively radioresistant and critically participate in the
regulation of contact allergic skin inflammation through
the production of proinflammatory mediators. This issue may
be resolved in future experiments using mice with cell type–
specific conditional deletion of the b-arrestin 2 gene.
As a potential explanation for our finding that b-arrestin 2
regulates the production of proinflammatory chemokines
under inflammatory conditions, we speculate that the absence
of b-arrestin 2 leads to increased NFkB activity. This assump-
tion is based on several studies demonstrating that b-arrestin 2
inhibits the phosphorylation and degradation of the NFkB
inhibitor IkBa. As a result, NFkB is no longer able to
translocate into the nucleus and NFkB target genes are
downregulated (Gao et al., 2004; Witherow et al., 2004). An
intriguing possibility is the involvement of anaphylatoxin
receptors such as C3aR and C5aR, two GPCRs that have
been shown to participate in the regulation of allergic skin
inflammation (Tsuji et al., 1997, 2000; Purwar et al., 2006;
Wang et al., 2013). In mast cells, it was recently shown that
b-arrestin 2 inhibits C3a-induced NFkB activation (Gupta
et al., 2012). C3aR is expressed by keratinocytes and
contributes to proinflammatory signaling (Purwar et al., 2006).
In conclusion, we demonstrate in our work that the multi-
functional adapter protein b-arrestin 2 has a pivotal role in the
regulation of contact allergic skin inflammation. Specifically,
b-arrestin 2 profoundly affects epidermal keratinocyte function
where its presence is essential to inhibit excessive production
of proinflammatory chemokines in response to TNF-a and
IFN-g, two cytokines secreted by allergen-specific T cells.
We propose that this helps limit the reactive recruitment of
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Figure 5. Increased secretion of proinflammatory chemokines by b-arrestin
2–deficient keratinocytes. (a, b) Mean levels (±SEM) of the indicated
chemokines determined by ELISA in supernatants from 10 individual primary
keratinocyte cultures generated from newborn Arrb2 / and wild-type (WT)
control mice that were stimulated with 1,000 U ml1 TNF-a, 1,000 U ml1
IFN-g, or were left untreated (Ctrl). (c) Mean mRNA expression levels of the
indicated genes relative to ubiquitin determined by quantitative real-time
reverse-transcriptase–PCR (2DCT ±SEM) in contact allergic ear tissue of
Arrb2 / and WT control mice harvested 48 hours after the second challenge
with DNFB (n¼ 5 per group). *Po0.05; **Po0.01; ***Po0.001. ND, not
determined; NS, not significant.
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myeloid immune cells, most notably neutrophils, and thereby
attenuates the allergic inflammatory response.
Our results may be of particular importance for the develop-
ment of strategies that target candidate GPCRs with ligands
that are biased toward selectively affecting G protein– or b
arrestin–dependent signaling pathways. This represents an
innovative area of current research for the treatment of pain
and cardiovascular diseases, which may also be applied for
the treatment of inflammatory diseases in the future.
MATERIALS AND METHODS
Mice
b-Arrestin 2–deficient (Arrb2 / ) C57BL/6 mice were a kind gift from
Professor Lefkowitz (Duke University Medical Center, Durham, NC).
Syngeneic (WT) C57BL/6 mice were purchased from Charles River,
Sulzfeld, Germany. Animals were bred in our animal facility. All
experiments were conducted according to the institutional and
national guidelines for the care and use of laboratory animals and
were approved by the local government authorities (Landesamt fu¨r
Natur, Umwelt und Verbraucherschutz North Rhine-Westphalia,
Recklinghausen, Germany).
CHS and acute irritative dermatitis
DNFB (Merck, Schwalbach, Germany) was diluted in acetone–olive
oil (4:1). Mice were sensitized by painting 50ml of 0.2% DNFB on the
shaved abdomen on days 0 and 1. Controls were treated with 50ml of
acetone–olive oil. For elicitation of CHS, ears of mice were painted
with 10ml of 0.3% DNFB on days 5, 12, and 19. Ear thickness was
measured 24, 48, and 96 hours after challenge. Fluorescein isothio-
cyanate isomer I (FITC, Sigma-Aldrich, Munich, Germany) was
diluted 1:1 in acetone:dibutylphtalat. Mice were sensitized by
painting 400ml of 0.5% FITC on the shaved abdomen on days 0, 1,
7, and 8. On day 14, mice were challenged by painting 20ml of 0.5%
FITC on the ear. Control mice were treated with vehicle only. Ear
swelling was measured 24 hours after challenge. 12-O-Tetradeca-
noylphorbol 13-acetate (Sigma-Aldrich) was dissolved in acetone and
3mg was applied once on one mouse to induce an acute irritative
dermatitis. Ear swelling was measured 2, 4, 6, and 24 hours after
application. In all models of inflammation, the degree of ear swelling
was determined by measuring the difference between the hapten or
12-O-tetradecanoylphorbol 13-acetate-exposed ear and the untreated
control ear with a spring-loaded caliper.
Histologic analyses of CHS
Paraffin-embedded ear tissue routinely was stained with hematoxylin
and eosin. For immunohistochemistry, primary antibodies for Gr1
(RB6-8C5, BD Pharmingen, Heidelberg, Germany) or CD3 (Serotec
MCA1477, 1:500, antigen unmasking: 10 minutes boiling in pH 6
buffer) were used. Slides were incubated with biotinylated rabbit anti-
rat IgG, Streptavidin-AP was added, and color reaction was devel-
oped using fast red (Dako, Hamburg, Germany). All histological
preparations were analyzed using a Leica DMLB microscope with a
connected digital camera.
Flow cytometry
Ear tissue was dissociated mechanically before incubation in
1 mg ml 1 collagenase D þ 0.02 mg ml 1 DNAseI (Roche,
Mannheim, Germany) in phosphate-buffered saline containing 5%
fetal bovine serum (Biochrom, Berlin, Germany) for 30 minutes at
37 1C. Staining was performed with the fluorochrome-conjugated rat
anti-mouse antibodies against CD45, CD11b, Ly6G, and Ly6C (BD
Biosciences, Heidelberg, Germany) and appropriate isotype controls.
Ly6G- and Ly6C-positive cells were analyzed in the CD45þ /
CD11bþ gate. Fluorescence was measured with an FACSCanto flow
cytometer system and data were analyzed with the FlowJo software.
Reverse transcriptase–PCR
Tissues were harvested 48 hours after the second challenge and
immediately snap-frozen in liquid nitrogen. Total RNA was isolated
using the Nucleospin RNA II kit (Macherey-Nagel, Du¨ren, Germany)
and was reverse-transcribed using Superscript III (Invitrogen,
Darmstadt, Germany). Quantitative PCR was performed using 3mg
of cDNA and Fast SYBR Green Master Mix (ABI, Darmstadt,
Germany). Relative gene expression was calculated using the 2DCT
method. Sequences of primers from 50–30: IL1b 5’-GGGCCTCAA
AGGAAAGAATC-3’ (forward), 5’-TTCTTTGGGTATTGCTTGGG-3’
(reverse), S1008A 5’-GAGTGTCCTCAGTTTGTGCAG-3’ (forward),
5’-GCCACACCCACTTTTATCA-3’ (reverse), IFN-g 5’-CTCTTCTT
GGATATCTGGAGG-3’ (forward), 5’-CCTGATTGTCTTTCAAGACT
TC-3’ (reverse), TNF-a 5’-GATTATGGCTCAGGGTCCAA-3’ (for-
ward), 5’-ACAGTCCAGGTCACTGTCCC-3’ (reverse), CCL2 5’-CTCA
GCCAGATGCAGTTAACG-3’ (forward), 5’-GCTGCTGGTGATCCTC
TTGT-3’ (reverse), CCL8 5’-CTGGGCCAGATAAGGCTCC-3’ (for-
ward), 5’-CATGGGGCACTGGATATTGT-3’ (reverse), CXCL1 5’-AC
CGAAGTCATAGCCACACTCA-3’ (forward), 5’-CCGTTACTTGGGG
ACACCTT-3’ (reverse), CXCL2 5’-CGCTGTCAATGCCTGAAG-3’
(forward), 5’-GGCGTCACACTCAAGCTCT-3’ (reverse), CXCL10
5’-GCCGTCATTTTCTGCCTCAT-3’ (forward), 5’-GCTTCCCTATGGC
CCTCATT-3’ (reverse), Ubi 5’-AGGCAAGACCATCACCTTGGACG-3’
(forward), 5’-CCATCACACCCAAGAACAAGCACA-3’ (reverse).
Preparation of bulk spleen and lymph node cells for adoptive
transfer experiments
For adoptive lymphocyte transfer experiments, Arrb2 / and WT
mice were sensitized with DNFB on days 0 and 1. On day 5, cell
suspensions were prepared from spleens and draining lymph nodes,
depleted of red blood cells, and washed twice in phosphate-buffered
saline. Bulk lymphocyte populations were transferred intravenously
into naı¨ve WT or Arrb2 / C57BL/6 mice (5 107cells per mouse).
On days 1 and 7 after transfer, CHS was elicited and ear swelling was
measured 48 hours after challenge, as previously described (Gaffal
et al., 2013).
Generation of bone marrow chimeric mice
Bone marrow cells were harvested from femurs and tibias of Arrb2 /
and WT mice, depleted of red blood cells, and washed twice in
phosphate-buffered saline. To generate bone marrow chimeric mice,
WT C57BL/6 and Arrb2 / mice were whole-body irradiated (9 Gy).
On the same day, bone marrow cells were transferred intravenously.
(6 106 cells per mouse) into irradiated WT or Arrb2 / recipients.
Six weeks after irradiation, mice were sensitized twice with 0.2%
DNFB and CHS was elicited as described.
Primary keratinocyte culture
Primary epidermal keratinocytes were isolated from the skin of
newborn mice according to standard procedures (Lichti et al.,
E Gaffal et al.
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2008). Cells were resuspended in keratinocyte growth medium 2
with 0.05 mM Ca2þ (PromoCell, Heidelberg, Germany). A total of
5 106 cells were seeded in 75-cm2 flasks and cultured until
confluent (37 1C, 5% CO2). Primary keratinocyte cultures were
stimulated with recombinant mouse TNF-a (1,000 U ml 1), IFN-g
(1,000 U ml 1), or were left untreated. Culture supernatants were
collected after 24 hours.
ELISA
Chemokine levels in supernatants were determined using commer-
cially available sandwich ELISAs for CCL2, CXCL1, and CCL8 (R&D
Systems, Wiesbaden, Germany) according to the manufacturer’s
protocols. OD was measured at 405 nm using an ELISA Reader.
Statistical analyses
Statistical analyses were performed with the nonparametric
Wilcoxon–Mann–Whitney U-test using the SPSS 12 software.
P-values are given as follows: *Po0.05; **Po0.01; ***Po0.001.
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